Your browser doesn't support javascript.
loading
Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach.
Guerrisi, Antonino; Russillo, Michelangelo; Loi, Emiliano; Ganeshan, Balaji; Ungania, Sara; Desiderio, Flora; Bruzzaniti, Vicente; Falcone, Italia; Renna, Davide; Ferraresi, Virginia; Caterino, Mauro; Solivetti, Francesco Maria; Cognetti, Francesco; Morrone, Aldo.
Afiliação
  • Guerrisi A; Radiology and Diagnostic Imaging Unit, Department of Clinical and Dermatological Research, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
  • Russillo M; Medical Oncology Unit 1, Department of Clinical and Cancer Research IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Loi E; Medical Physics and Expert Systems Laboratory, 3 Department of Research and Advanced Technologies, Istituti Fisioterapici Ospitalieri - IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ganeshan B; Institute of Nuclear Medicine, Imaging Department, University College Hospital, London, United Kingdom.
  • Ungania S; Medical Physics and Expert Systems Laboratory, 3 Department of Research and Advanced Technologies, Istituti Fisioterapici Ospitalieri - IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Desiderio F; Radiology and Diagnostic Imaging Unit, Department of Clinical and Dermatological Research, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
  • Bruzzaniti V; Medical Physics and Expert Systems Laboratory, 3 Department of Research and Advanced Technologies, Istituti Fisioterapici Ospitalieri - IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Falcone I; Medical Oncology Unit 1, Department of Clinical and Cancer Research IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Renna D; Medical Oncology 1, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • Ferraresi V; Medical Oncology Unit 1, Department of Clinical and Cancer Research IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Caterino M; Radiology and Diagnostic Imaging Unit, Department of Clinical and Dermatological Research, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
  • Solivetti FM; Radiology and Diagnostic Imaging Unit, Department of Clinical and Dermatological Research, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
  • Cognetti F; Medical Oncology Unit 1, Department of Clinical and Cancer Research IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Morrone A; Scientific Director, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
Front Oncol ; 11: 704607, 2021.
Article em En | MEDLINE | ID: mdl-34692481
ABSTRACT
In the era of artificial intelligence and precision medicine, the use of quantitative imaging methodological approaches could improve the cancer patient's therapeutic approaches. Specifically, our pilot study aims to explore whether CT texture features on both baseline and first post-treatment contrast-enhanced CT may act as a predictor of overall survival (OS) and progression-free survival (PFS) in metastatic melanoma (MM) patients treated with the PD-1 inhibitor Nivolumab. Ninety-four lesions from 32 patients treated with Nivolumab were analyzed. Manual segmentation was performed using a free-hand polygon approach by drawing a region of interest (ROI) around each target lesion (up to five lesions were selected per patient according to RECIST 1.1). Filtration-histogram-based texture analysis was employed using a commercially available research software called TexRAD (Feedback Medical Ltd, London, UK; https//fbkmed.com/texrad-landing-2/) Percentage changes in texture features were calculated to perform delta-radiomics analysis. Texture feature kurtosis at fine and medium filter scale predicted OS and PFS. A higher kurtosis is correlated with good prognosis; kurtosis values greater than 1.11 for SSF = 2 and 1.20 for SSF = 3 were indicators of higher OS (fine texture 192 HR = 0.56, 95% CI = 0.32-0.96, p = 0.03; medium texture HR = 0.54, 95% CI = 0.29-0.99, p = 0.04) and PFS (fine texture HR = 0.53, 95% CI = 0.29-0.95, p = 0.03; medium texture HR = 0.49, 209 95% CI = 0.25-0.96, p = 0.03). In delta-radiomics analysis, the entropy percentage variation correlated with OS and PFS. Increasing entropy indicates a worse outcome. An entropy variation greater than 5% was an indicator of bad prognosis. CT delta-texture analysis quantified as entropy predicted OS and PFS. Baseline CT texture quantified as kurtosis also predicted survival baseline. Further studies with larger cohorts are mandatory to confirm these promising exploratory results.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article